Pharmacovigilance – News and Features

A new molecule could offer non-hormonal contraceptive options for people who produce sperm, according to new research published in The American Chemical Society (ACS)’s Journal of Medicinal Chemistry.

A new study has described a novel chemo- and immunotherapy that has proven to be a promising treatment for dogs with cancer.

A newly published paper shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

The world’s first international clinical guidelines to help prevent and treat heart complications in children undergoing cancer treatment have been created.

A new study suggests that female patients with a type of lymphoma respond better to radiotherapy when treated in the afternoon than in the morning.

Measurements indicate that whenever UV lamps used for disinfection were switched on, both gas and small particle concentrations increased considerably, not returning to their original levels until 30 to 40 minutes after the lamps were switched off.

This article overviews the science behind the potential use of RRx-001as a “radiation buster” with anti-inflammatory and anti-free radical properties to prevent or reduce both GI-ARS and H-ARS.

Using bottlebrush-shaped nanoparticles that can be loaded with multiple drugs, researchers calculated and delivered the optimal ratio of three cancer drugs used to treat multiple myeloma.

MSG was given a rather unsavory reputation in the 1960s. But did MSG ever deserve its distasteful status, or is it simply just a misunderstood constituent of South Asian cuisine?

A study has demonstrated that long-term treatment of healthy mice from middle age with a drug currently used to treat cancer can increase their lifespan by an average of ten percent.